Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Pankreas » Neoplasms 11. November 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Esophagus
Pankreas
Neoplasms
Pancreatitis
Others
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3107  Previews Next
   
   Articles 1 - 20 / 62137  
   
Randomized multicentre Phase 2 clinical trial of non-viral gene therapy for pancreatic cancer: clinical and molecular findings.
Cancer Drug Resist
Buscail L, Lebrin M, Hanoun N, Gourgou S, Dorat N, Vernejoul F, Cambois G, Gross F, Guimbaud R, Bournet B, Mitry E, Artru P, Ouvrier D, Flori N, Thuillier F, Barthet M, Tiraby M, Cordelier P, Thergap-2 Investigator Group.
PMID: 43011677 [PubMed]


Sex and Etiology Differences in Overall Survival and Adverse Liver Events in Hepatocellular Carcinoma: An International Multicenter Study.
MedComm (2020)
Xia F, Huang H, Guo B, Xu M, Gasque RA, Chen Q, Zhang Q, Wu Z, Chen W, Huang Z, Liu Y, Liu L, Han S, He S, Li D, Xiang B, Zhou C, Zhou W, Li Y, Lu S, Jiang C, Duan X, Liao Y, Gu J, Zhou B, Cai W, Zhang J, Yin H, Xia G, Wan Y, Li J, Xia X, Sun H, Wang S, Chen Y, Yuan F, Lin F, Cai W, Gao H, Ren L, Chen X, Geng T, Giannone F, Moctezuma-Velazquez C, Zhang E, Andraus W, Cheng Q, Zhang Z.
PMID: 43011222 [PubMed]


Awareness of the signs and symptoms of pancreatic cancer: a cross-sectional study from a developing country setting.
Future Sci OA
Rataan AO, Amawi H, Alsous M, Alrosan AZ, Albawaana A, Alzoubi KH.
PMID: 43010177 [PubMed]


Stimuli-responsive CRISPR-based genome editing delivery system for cancer treatment: A review of fundamentals and applications.
J Control Release
Jiang Y, Sun R, Zhang J, Wang C, Chen X, Wu D.
PMID: 43009024 [PubMed - as supplied by publisher]


Robotic pancreatic enucleation versus laparoscopic pancreatic enucleation: a meta-analysis.
J Robot Surg
Shi J, Zhu C, Zhou Y.
PMID: 43007558 [PubMed - indexed for MEDLINE]


Targeting lipid metabolism to overcome immunosuppression and enhance immunotherapy or chemotherapy sensitivity in pancreatic cancer: from immunosuppressive mechanisms to therapeutic opportunities.
Mol Biol Rep
Zhan T, Liu Y, Yan J, Huang X.
PMID: 43007394 [PubMed - indexed for MEDLINE]


Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound-guided sampling of pancreatic ductal adenocarcinoma.
Cancer Cytopathol
Gao Y, Canty C, Prakash LR, Coronel E, Katz MHG, Snyder RA, Roy-Chowdhuri S.
PMID: 43006245 [PubMed - indexed for MEDLINE]


Predicting complications after hepatectomy for hepatocellular carcinoma: a narrative review focused on liver failure.
Front Oncol
Zhang H, Cai J, Yang Z, Ye T, Zhao Z, Chen X, Wan J.
PMID: 43005667 [PubMed]


CT referrals and cancer detection in patients referred by general practitioners with non-specific symptoms and signs of cancer: A retrospective study.
Acta Radiol Open
Ohana NL, Axelsen J, Wilkinson MS, Graumann O, Sivesgaard K, Buus TW, Vedsted P, Midtgaard A, Greve SB, Larsen SKA.
PMID: 43005528 [PubMed]


Current and emerging strategies to enhance chemotherapeutic efficacy in pancreatic ductal adenocarcinoma.
BMC Med
Hackett D, Kane LE, Prina-Mello A, Maher SG.
PMID: 43004418 [PubMed - indexed for MEDLINE]


Exercise-containing multimodal prehabilitation on functional outcome of patients with hepatobiliary and pancreatic cancer after surgery: a meta-analysis.
BMC Cancer
She Z, Jiang Q, Lu W.
PMID: 43004285 [PubMed - indexed for MEDLINE]


Ras signaling in cancer: From molecular mechanisms to next-generation therapeutic inhibitors.
Biochim Biophys Acta Rev Cancer
Hossain J, Choudhury D, Bhattacharyya S, Vedeshachaitanya B, Malakar P.
PMID: 43003238 [PubMed - as supplied by publisher]


Controversies in NEN: An ENETS position statement on the diagnosis and treatment of mixed neuroendocrine/non-neuroendocrine neoplasms of the digestive system.
J Neuroendocrinol
Spada F, Kasajima A, de Mestier L, Luong TV, Marinoni I, Milione M, Sadanandam A, Speel EJ, Koumarianou A, Caruso D, Pascher A, Sorbye H.
PMID: 43003098 [PubMed - indexed for MEDLINE]


Towards precision oncology in pancreatic cancer: Diagnostic and prognostic biomarkers from conventional methods to liquid biopsy and artificial intelligence-based approaches.
Biochem Biophys Res Commun
Maghsoodi N, Ameri M, Absalan F, Esmaeili M, Ramezani A.
PMID: 43002872 [PubMed - as supplied by publisher]


Cancer Risks Associated With Germline BARD1 Pathogenic/Likely Pathogenic Variants: A Multicenter Study of 445 Families.
JCO Precis Oncol
Homer JP, Demeure MJ, Yao Y, Hanson K, Ramczyk B, Lichtenberg EC, Cohen SA, Crow K, Florido ME, Powell KP, Koerner CM, DeGrandchamp ME, Zrada C, Gonzales MB, Collier RA, Chien ES, Torres CB, Lin J, Sigsbee S, Smith SG, Adar TA, Berry DK, Gewandter K, Wright N, Senter L, Brown J, Baker MJ, Morse K, Scouten R, Brown SM, van den Berg D, Tran LB, Childers K, Gordon O, Bond E, Pagan B, Woo S, Mandich H, Nathan D, Karlan BY, Ku L, De Rosa D, Chang EY, Reed L, Brown EB, Patel G, Darabi S, BARD1 Collaborators.
PMID: 43002722 [PubMed - indexed for MEDLINE]


PancreaGuide for Computed Tomography Report Interpretation and Perioperative Consultation in Pancreatic Cancer: Development and Retrospective Evaluation of a Knowledge-Augmented Large Language Model Agent.
J Med Internet Res
Kuang T, Wang R, Zhang S, Sun Y, Zhou J, Wu Z, Peng B.
PMID: 43002664 [PubMed - indexed for MEDLINE]


Ecosystem Determinants of Therapeutic Resistance in Pancreatic Cancer: Implications for Precision Oncology.
Cancer Invest
Shahiwala AF.
PMID: 43001337 [PubMed - as supplied by publisher]


RNA sequencing and proteomic analysis of diagnostic biopsies from colorectal and pancreatic cancer.
Biochem Biophys Rep
Nordlund V, Haram M, Hofsli E, Røe OD, Davies CL, Mjelle R.
PMID: 43001289 [PubMed]


New-Onset Diabetes as a Red Flag for Pancreatic Cancer: From Metabolic Clues to Earlier Detection in Primary Care.
Cureus
Camacho-Flores L, Alvarez A, Bonet Vazquez R, Benet P, Alfonso García CB, Marti Del Rio M.
PMID: 43001179 [PubMed]


Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis".
Clin Mol Hepatol
Zhang SJ, Gao G.
PMID: 43001021 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 62137    Page 1 of 3107  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1